US, Gates Foundation Plan $200M for Sickle Cell, HIV Cures
Thursday, 24 October 2019 10:50 WIB | GLOBAL |Global

The U.S. government and the Bill and Melinda Gates Foundation pledged Wednesday to jointly invest $200 million over the next four years to achieve affordable gene therapy-based cures for sickle cell disease (SCD) and HIV.

The administration of President Donald Trump announced earlier this year its intention to end the HIV epidemic over the next decade and has also identified SCD, which disproportionately affects people of African descent, as a condition requiring greater attention.

Gene therapy is a relatively new area of medicine designed to replace faulty genes in the body that are responsible for a disorder, and has been responsible for new treatments for blindness and certain types of leukemia.

But the treatments are complex and costly, ruling them out as an option for most of the world.

Francis Collins, director of the National Institutes of Health, said the collaboration would focus therefore on "access, scalability and affordability" to make sure the eventual treatments are available globally.

The NIH and Gates Foundation aim to achieve clinical trials in the United States and countries in sub-Saharan Africa within the next seven to 10 years.

Source : VOA

RELATED NEWS

European Signatories Call on Iran to Reverse Actions Against Nuclear Deal
Tuesday, 12 November 2019 23:20 WIB

France, Germany, Britain and the European Union say they are "extremely concerned" about Iran's renewed uranium enrichment activities and what they call "regrettable acceleration of Iran's disengagement" from commitments it made under the 2015 agreement regarding the country's nuclear program. In a...

Tensions High Ahead of Erdogan-Trump Meeting
Tuesday, 12 November 2019 17:59 WIB

Turkish  President Recep Tayyip Erdogan visits Washington this week to meet President Donald Trump, a meeting some consider an opportunity to reset relations that have been strained over numerous policy differences. Turkey's military operation against the Syrian Kurdish militia, the YPG, is ex...

Magnitude-5.4 Earthquake Felt in Southern France
Monday, 11 November 2019 23:21 WIB

The French earthquake detection agency says a moderate tremor measuring 5.4 in magnitude has struck southern France in a remote area of the Drome department between Lyon and Marseille. The agency said the quake occurred before noon Monday and its epicenter was situated near the town of Montelimar i...

Iran Calls Ex-FBI Agent's Case a 'Missing Person' File
Monday, 11 November 2019 19:26 WIB

Iran on Sunday said an open Revolutionary Court case involving an ex-FBI agent who disappeared there in 2007 on an unauthorized CIA mission ``was a missing person'' filing, not a sign that the man was being prosecuted. Foreign Ministry spokesman Abbas Mousavi's comments come as a new Iranian acknow...

Pompeo Issues Stark Warning to Russia, China
Saturday, 9 November 2019 00:03 WIB

Three decades after the fall of the Berlin Wall, the United States said Washington and its allies are still confronting formidable communist adversaries and the free world needs to continue to defend against threats from Russia and China. In a speech near Berlin's iconic Brandenburg Gate, Secretary...

POPULAR NEWS
Tuesday, 12 November 2019 07:50
Asia shares turn sluggish ahead of Trump speech
Monday, 11 November 2019 15:32
Hong Kong Stocks End With Steep Losses
ANOTHER NEWS
Tokyo stocks close lower as investors await Fed
Wednesday, 13 November 2019 13:24 WIB Tokyo stocks closed lower Wednesday as cautious investors awaited remarks by the US Federal Reserve chief and key Chinese data later in the week. The benchmark Nikkei 225 index fell 0.85 percent or 200.14 points to end at 23,319.87 while the...

DISCLAIMER

Seluruh materi atau konten yang tersaji di dalam website ini hanya bersifat informatif saja, dan tidak dimaksudkan sebagai pegangan serta keputusan dalam investasi atau jenis transaksi lainnya. Kami tidak bertanggung jawab atas segala akibat yang timbul dari penyajian konten tersebut. Semua pihak yang mengunjungi website ini harus membaca Terms of Service (Syarat dan Ketentuan Layanan) terlebih dahulu dan dihimbau untuk melakukan analisis secara independen serta memperoleh saran dari para ahli dibidangnya.